ALGN
Price
$171.37
Change
-$2.39 (-1.38%)
Updated
Jun 23, 04:02 PM (EDT)
Capitalization
12.44B
36 days until earnings call
Intraday BUY SELL Signals
GKOS
Price
$133.44
Change
+$2.25 (+1.72%)
Updated
Jun 23, 04:08 PM (EDT)
Capitalization
7.71B
43 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGN vs GKOS

ALGN vs GKOS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALGN vs. GKOS commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Hold and GKOS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (ALGN: $173.76 vs. GKOS: $131.19)
Brand notoriety: ALGN: Notable vs. GKOS: Not notable
ALGN represents the Pharmaceuticals: Other, while GKOS is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ALGN: 118% vs. GKOS: 51%
Market capitalization -- ALGN: $12.44B vs. GKOS: $7.71B
ALGN [@Pharmaceuticals: Other] is valued at $12.44B. GKOS’s [@Medical/Nursing Services] market capitalization is $7.71B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $142.71B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $152.98B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.5B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 1 FA rating(s) are green whileGKOS’s FA Score has 0 green FA rating(s).

  • ALGN’s FA Score: 1 green, 4 red.
  • GKOS’s FA Score: 0 green, 5 red.
According to our system of comparison, GKOS is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 6 TA indicator(s) are bullish while GKOS’s TA Score has 7 bullish TA indicator(s).

  • ALGN’s TA Score: 6 bullish, 4 bearish.
  • GKOS’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, GKOS is a better buy in the short-term than ALGN.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а -2.52% price change this week, while GKOS (@Medical/Nursing Services) price change was +0.81% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.31%. For the same industry, the average monthly price growth was -0.98%, and the average quarterly price growth was -14.76%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.22%. For the same industry, the average monthly price growth was -3.84%, and the average quarterly price growth was -16.30%.

Reported Earning Dates

ALGN is expected to report earnings on Jul 29, 2026.

GKOS is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.31% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.22% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($12.4B) has a higher market cap than GKOS($7.71B). GKOS YTD gains are higher at: 16.190 vs. ALGN (11.278). ALGN has higher annual earnings (EBITDA): 877M vs. GKOS (-144M). ALGN has more cash in the bank: 1.06B vs. GKOS (277M). GKOS has less debt than ALGN: GKOS (103M) vs ALGN (116M). ALGN has higher revenues than GKOS: ALGN (4.1B) vs GKOS (551M).
ALGNGKOSALGN / GKOS
Capitalization12.4B7.71B161%
EBITDA877M-144M-609%
Gain YTD11.27816.19070%
P/E Ratio29.20N/A-
Revenue4.1B551M743%
Total Cash1.06B277M383%
Total Debt116M103M113%
FUNDAMENTALS RATINGS
ALGN vs GKOS: Fundamental Ratings
ALGN
GKOS
OUTLOOK RATING
1..100
139
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
10064
SMR RATING
1..100
6998
PRICE GROWTH RATING
1..100
2647
P/E GROWTH RATING
1..100
6359
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALGN's Valuation (70) in the Medical Specialties industry is in the same range as GKOS (95). This means that ALGN’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (64) in the Medical Specialties industry is somewhat better than the same rating for ALGN (100). This means that GKOS’s stock grew somewhat faster than ALGN’s over the last 12 months.

ALGN's SMR Rating (69) in the Medical Specialties industry is in the same range as GKOS (98). This means that ALGN’s stock grew similarly to GKOS’s over the last 12 months.

ALGN's Price Growth Rating (26) in the Medical Specialties industry is in the same range as GKOS (47). This means that ALGN’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's P/E Growth Rating (59) in the Medical Specialties industry is in the same range as ALGN (63). This means that GKOS’s stock grew similarly to ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNGKOS
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 8 days ago
71%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 21 days ago
74%
Bearish Trend 7 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signal:
Gain/Loss:
GKOS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNTA1.930.25
+14.88%
Genenta Science SpA
NPO387.658.00
+2.11%
Enpro
PERI8.630.12
+1.41%
Perion Network Ltd
STBA47.310.47
+1.00%
S&T Bancorp
FIGXU10.340.07
+0.68%
Figx Capital Acquisition Corp

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been loosely correlated with BAX. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGN jumps, then BAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
-4.57%
BAX - ALGN
63%
Loosely correlated
-1.16%
NVST - ALGN
57%
Loosely correlated
-1.54%
LUNG - ALGN
52%
Loosely correlated
-0.78%
XRAY - ALGN
51%
Loosely correlated
-1.74%
ILMN - ALGN
48%
Loosely correlated
-0.34%
More

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
+0.39%
ISRG - GKOS
51%
Loosely correlated
-0.94%
NTRA - GKOS
48%
Loosely correlated
-1.13%
RDNT - GKOS
48%
Loosely correlated
+3.72%
TWST - GKOS
46%
Loosely correlated
-2.91%
ALGN - GKOS
43%
Loosely correlated
-4.57%
More